Hyaluronic acid modified MPEG-b-PAE block copolymer aqueous micelles for efficient ophthalmic drug delivery of hydrophobic genistein

References

• Chuang HS, Chen YJ, Cheng HP. (2018). Enhanced diffusometric immunosensing with grafted gold nanoparticles for detection of diabetic retinopathy biomarker tumor necrosis factor-α. Biosens Bioelectron 101:75–83.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. (2013). Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev 65:36–48.
   PubMed Web of Science ®Google Scholar
• Amrite AC, Kompella UB. (2005). Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration. J Pharm Pharmacol 57:1555–63.
   PubMed Web of Science ®Google Scholar
• Bakri SJ, Omar AF. (2012). Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion. J Ocul Pharmacol Ther 28:547–9.
   PubMed Web of Science ®Google Scholar
• Balzus B, Sahle FF, Hönzke S, et al. (2017). Formulation and ex vivo evaluation of polymeric nanoparticles for controlled delivery of corticosteroids to the skin and the corneal epithelium. Eur J Pharm Biopharm 115:122–30.
   PubMed Web of Science ®Google Scholar
• Bisht R, Jaiswal JK, Verity F, et al. (2017). Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery. J Drug Deliv Sci Technol 40:142–56.
   Web of Science ®Google Scholar
• Farnoodian M, Wang SJ, Dietz J, et al. (2017). Negative regulators of angiogenesis: important targets for treatment of exudative AMD. Clin Sci 131:1763–80.
   PubMed Web of Science ®Google Scholar
• Gao G, Li Y, Zhang D, et al. (2001). Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett 489:270–6.
   PubMed Web of Science ®Google Scholar
• Hennig R, Goepferich A. (2015). Nanoparticles for the treatment of ocular neovascularizations. Eur J Pharm Biopharm 95:294–306.
   PubMed Web of Science ®Google Scholar
• Ibrahim AS, El-Shishtawy MM, Pena A Jr, Liou GI. (2010). Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 16:2033–42.
   PubMed Web of Science ®Google Scholar
• Ioanna Z, Christian S, Christian G, et al. (2018). Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 256:325–32.
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. (2008). Age-related macular degeneration. N Engl J Med 358:2606–17.
   PubMed Web of Science ®Google Scholar
• Kane FE, Burdan J, Cutino A, Green KE. (2008). Iluvien: a new sustained delivery technology for posterior eye disease. Expert Opin Drug Deliv 5:1039–46.
   PubMed Web of Science ®Google Scholar
• Kang-Mieler JJ, Osswald CR, Mieler WF. (2014). Advances in ocular drug delivery: emphasis on the posterior segment. Expert Opin Drug Deliv 11:1647–60.
   PubMed Web of Science ®Google Scholar
• Kureishi Y, Luo Z, Shiojima I, et al. (2000). The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6:1004–10.
   PubMed Web of Science ®Google Scholar
• Lajunen T, Nurmi R, Kontturi L, et al. (2016). Light activated liposomes: functionality and prospects in ocular drug delivery. J Control Release 244:157–66.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Li J, et al. (2012). Diclofenac/biodegradable polymer micelles for ocular applications. Nanoscale 4:4667–73.
   PubMed Web of Science ®Google Scholar
• Lim C, Kim DW, Sim T, et al. (2016). Preparation and characterization of a lutein loading nanoemulsion system for ophthalmic eye drops. J Drug Deliv Sci Technol 36:168–74.
   Web of Science ®Google Scholar
• Liu S, Jones L, Gu FX. (2012). Nanomaterials for ocular drug delivery. Macromol Biosci 12:608–20.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiao Y, Wang Y, et al. (2008). Polysaccharides-based nanoparticles as drug delivery systems. Adv Drug Deliv Rev 60:1650–62.
   PubMed Web of Science ®Google Scholar
• Luo Q, Zhao J, Zhang X, Pan W. (2011). Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 403:185–91.
   PubMed Web of Science ®Google Scholar
• Moustafa MA, Elnaggar YSR, El-Refaie WM, et al. (2017). Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect. Int J Pharm 534:14–24.
   PubMed Web of Science ®Google Scholar
• Oh EJ, Park K, Kim KS, et al. (2010). Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release 141:2–12.
   PubMed Web of Science ®Google Scholar
• Rafie F, Javadzadeh Y, Javadzadeh AR, et al. (2010). In vivo evaluation of novel nanoparticles containing dexamethasone for ocular drug delivery on rabbit eye. Curr Eye Res 35:1081–9.
   PubMed Web of Science ®Google Scholar
• Sanchez-Lopez E, Egea MA, Davis BM, et al. (2018). Memantine-loaded PEGylated biodegradable nanoparticles for the treatment of glaucoma. Small 14. doi: 10.1002/smll.201701808.
   PubMed Web of Science ®Google Scholar
• Sangwan VS, Pearson PA, Paul H, Comstock TL. (2015). Use of the fluocinolone acetonide intravitreal implant for the treatment of noninfectious posterior uveitis: 3-year results of a randomized clinical trial in a predominantly Asian population. Ophthalmol Ther 4:1–19.
   PubMed Web of Science ®Google Scholar
• Singh SR, Grossniklaus HE, Kang SJ, et al. (2009). Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. Gene Ther 16:645–59.
   PubMed Web of Science ®Google Scholar
• Upadhayay PN, Kumar M, Pathak K. (2016). Norfloxacin loaded pH triggered nanoparticulate in-situ gel for extraocular bacterial infections: optimization, ocular irritancy and corneal toxicity. Iran J Pharm Res 15:3–22.
   PubMed Web of Science ®Google Scholar
• Varghese OP, Sun W, Hilborn J, Ossipov DA. (2009). In situ cross-linkable high molecular weight hyaluronan-bisphosphonate conjugate for localized delivery and cell-specific targeting: a hydrogel linked prodrug approach. J Am Chem Soc 131:8781–3.
   PubMed Web of Science ®Google Scholar
• Verhoeven RS, Garcia A, Robeson R, et al. (2018). Nonclinical development of ENV905 (Difluprednate) ophthalmic implant for the treatment of inflammation and pain associated with ocular surgery. J Ocul Pharmacol Ther 34:161–9.
   PubMed Web of Science ®Google Scholar
• Villanueva JR, Navarro MG, Villanueva LR. (2016). Dendrimers as a promising tool in ocular therapeutics: latest advances and perspectives. Int J Pharm 511:359–66.
   PubMed Web of Science ®Google Scholar
• Wang B, Zou Y, Li H, et al. (2005). Genistein inhibited retinal neovascularization and expression of vascular endothelial growth factor and hypoxia inducible factor 1 alpha in a mouse model of oxygen-induced retinopathy. J Ocul Pharmacol Ther 21:107.
   PubMed Web of Science ®Google Scholar
• Witmer AN, Vrensen GFJM, Van Noorden CJ, et al. (2003). Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1–29.
   PubMed Web of Science ®Google Scholar
• Xu L, Wang YY, Nguyen VT, Chen JG. (2016). Effects of topical antibiotic prophylaxis on wound healing after flapless implant surgery: a pilot study. J Periodontol 87:275–80.
   PubMed Web of Science ®Google Scholar
• Xu SM, Liang ZJ, Du Q, et al. (2018). A systematic study on the prevention and treatment of retinopathy of prematurity in China. BMC Ophthalmol 18:44.
   PubMed Web of Science ®Google Scholar
• Yavuz B, Pehlivan SB, Kaffashi A, et al. (2016). In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants. Drug Deliv 23:3279–84.
   PubMed Web of Science ®Google Scholar